Form 8-K - Current report:
SEC Accession No. 0000950170-24-123411
Filing Date
2024-11-07
Accepted
2024-11-07 16:27:33
Documents
12
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tecx-20241107.htm   iXBRL 8-K 39769
2 EX-99.1 tecx-ex99_1.htm EX-99.1 132446
  Complete submission text file 0000950170-24-123411.txt   297618

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tecx-20241107.xsd EX-101.SCH 24872
14 EXTRACTED XBRL INSTANCE DOCUMENT tecx-20241107_htm.xml XML 4711
Mailing Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472 (339) 666-3320
Tectonic Therapeutic, Inc. (Filer) CIK: 0001681087 (see all company filings)

EIN.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 241436270
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)